Clinical Trials
48 trialsNivolumab and Ipilimumab in Treating Patients With Rare Tumors
National Cancer Institute (NCI)
Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors
National Cancer Institute (NCI)
A Study of ERAS-601 in People With Chordoma
Memorial Sloan Kettering Cancer Center
Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
Dana-Farber Cancer Institute
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Chordoma
Sichuan Baili Pharmaceutical Co., Ltd.
FLAGSHP-1
Erasca, Inc.
PALANGI3
Centre Oscar Lambret
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
University of Florida
Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma
M.D. Anderson Cancer Center
Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base
Quironsalud
Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
SACRO
Italian Sarcoma Group
Nilotinib With Radiation for High Risk Chordoma
Massachusetts General Hospital
Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers
Dana-Farber Cancer Institute
Proton Beam Therapy for Chordoma Patients
M.D. Anderson Cancer Center
Proton Radiation for Chordomas and Chondrosarcomas
Abramson Cancer Center at Penn Medicine
A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
Novartis
TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer
Bavarian Nordic
QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma.
ImmunityBio, Inc.
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
Sarcoma Oncology Research Center, LLC
Afatinib in Locally Advanced and Metastatic Chordoma
Leiden University Medical Center
Pembrolizumab and Pemetrexed for Progressive Chordoma
Saint John's Cancer Institute
A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors
C4 Therapeutics, Inc.
P1V2
Centre Antoine Lacassagne
QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma
NantCell, Inc.
Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma
Jonsson Comprehensive Cancer Center
PalboSarc
Grupo Espanol de Investigacion en Sarcomas
ISAC
Heidelberg University
Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma
Xuanwu Hospital, Beijing
A Prospective Study of Surgical Treatment Strategies for Chordoma
Xuanwu Hospital, Beijing
BN Brachyury and Radiation in Chordoma
Bavarian Nordic
NCT-PMO-1601
University Hospital Heidelberg
Pemetrexed for the Treatment of Chordoma
Saint John's Cancer Institute
IMRiS
University College, London
Stereotactic Body Radiotherapy for Spine Tumors
Mercy Research
Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies
BioMed Valley Discoveries, Inc
Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas
Medical College of Wisconsin
CSSG-03
Peking University People's Hospital
Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors
Medical College of Wisconsin
Trial of Dasatinib in Advanced Sarcomas
Sarcoma Alliance for Research through Collaboration
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
Masonic Cancer Center, University of Minnesota
Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine
Massachusetts General Hospital
Efficacy and Safety of Imatinib in Chordoma
Novartis
Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas
Massachusetts General Hospital
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Novartis
Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer
National Cancer Institute (NCI)
Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma
University of Virginia
HIT-1
Heidelberg University